ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.75
0.28%
US Tech 100
18,318.00
0.95%
S&P 500
5,304.72
0.70%
US Dollar vs CAD
1.36308
-0.28%
Bitcoin
70,255.27
2.55%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Belite Bio Inc (BLTE)

  7. Belite Bio Inc (BLTE) News

BLTE

Belite Bio (BLTE)

Belite Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BLTE
DateTimeSourceHeadlineSymbolCompany
05/17/202410:36AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
05/16/20241:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
05/14/20247:00AMGlobeNewswire Inc.Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor ConferenceNASDAQ:BLTEBelite Bio Inc
05/13/20248:57PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLTEBelite Bio Inc
05/13/20248:50PMGlobeNewswire Inc.Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:BLTEBelite Bio Inc
05/13/20247:00AMGlobeNewswire Inc.Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:BLTEBelite Bio Inc
05/08/20247:00AMGlobeNewswire Inc.Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial ResultsNASDAQ:BLTEBelite Bio Inc
05/06/20247:15AMGlobeNewswire Inc.Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On TinlarebantNASDAQ:BLTEBelite Bio Inc
05/06/20247:00AMGlobeNewswire Inc.Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual MeetingNASDAQ:BLTEBelite Bio Inc
05/01/20243:15PMGlobeNewswire Inc.Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual MeetingNASDAQ:BLTEBelite Bio Inc
04/25/20246:15PMGlobeNewswire Inc.Belite Bio Announces $25 Million Registered Direct OfferingNASDAQ:BLTEBelite Bio Inc
03/22/20247:00AMGlobeNewswire Inc.Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in JapanNASDAQ:BLTEBelite Bio Inc
03/11/20249:28PMGlobeNewswire Inc.Belite Bio Announces Availability of Annual Report on Form 20-F Through Company WebsiteNASDAQ:BLTEBelite Bio Inc
03/11/20248:27PMGlobeNewswire Inc.Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:BLTEBelite Bio Inc
03/06/20247:00AMGlobeNewswire Inc.Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:BLTEBelite Bio Inc
03/04/20247:00AMGlobeNewswire Inc.Belite Bio to Participate in the Leerink Partners Global Biopharma ConferenceNASDAQ:BLTEBelite Bio Inc
02/12/20248:08PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLTEBelite Bio Inc
02/12/20247:40PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLTEBelite Bio Inc
02/07/20247:00AMGlobeNewswire Inc.Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:BLTEBelite Bio Inc
12/28/20233:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
12/28/20233:15PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
11/30/20237:00AMGlobeNewswire Inc.Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor ConferenceNASDAQ:BLTEBelite Bio Inc
11/28/20234:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
11/20/20237:00AMGlobeNewswire Inc.Belite Bio to Participate in the BTIG Ophthalmology DayNASDAQ:BLTEBelite Bio Inc
11/16/20233:41PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
11/16/20233:36PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
11/13/20237:15PMGlobeNewswire Inc.Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial ResultsNASDAQ:BLTEBelite Bio Inc
11/10/20237:35AMGlobeNewswire Inc.Deutsche Bank ADR Investor Conference: Presentations Now Available for Online ViewingNASDAQ:BLTEBelite Bio Inc
11/07/20237:00AMGlobeNewswire Inc.Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial ResultsNASDAQ:BLTEBelite Bio Inc
11/06/20233:00PMGlobeNewswire Inc.Belite Bio, Inc. to present at the Deutsche Bank ADR Virtual Investor Conference on 8 November 2023NASDAQ:BLTEBelite Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BLTE

Your Recent History

COIN
TCHUST
TCH Token
EU
N736S
N736S
AMEX
MTNB
Matinas Biopharma
NASDAQ
JCICW
Jack Creek Investment
NASDAQ
RMTI
Rockwell Medical
DBI
G73T
DAXglobal Coal Index EUR...
TSXV
CII.P
Corporate Catalyst Acquisition
BIT
F18655
Vontobel Financial Produ...
COIN
TKGUSD
Takamaka Green Coin
NASDAQ
PFTAU
Perception Capital Corpo...
NYSE
MFA-B
MFA Financial
BIT
F17464
Vontobel Financial Produ...
EU
SSTEP
Euronext S Total 030323 ...
NEO
CUSA.B
CI US 500 Index ETF
EU
IMFED
Lyxor MFED iNav
CSE
SURE
SureNano Science
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved